"$5/$7/$10" buyout -- anyone even whisper somethin
Post# of 147650
Going to need to add a few zeros to the math.
CCR5 pathway iP.
No SAE's
Cross BBB
Cross placenta
Full CCR5 RO on mother AND babies beyond birth
Great P2 liver data
Murine--- "Significantly" fibrosis reversal
Glioblastoma data due
Colorectal Cancer protocol arriving
HIV Inflammation protocol arriving
Chronic Fatigue protocol arriving
Alzheimer’s patient foundation $
Previous mTNBC data in hand
mTNBC protocol design with 3 universities
** No telling what Long Acting Leronlimab is up to, after that placenta/CCR5 publication
Yea.....let's sell the company on the cheap